NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

呼吸健康管理技術-成長機會

Respiratory Health Management Technology Growth Opportunities

出版商 Frost & Sullivan 商品編碼 1022234
出版日期 內容資訊 英文 74 Pages
商品交期: 最快1-2個工作天內
價格
呼吸健康管理技術-成長機會 Respiratory Health Management Technology Growth Opportunities
出版日期: 2021年07月19日內容資訊: 英文 74 Pages
簡介

呼吸系統疾病與氣道和肺的結構有關,並影響氣囊、間質、血管、胸膜和胸壁。常見的呼吸系統疾病包括慢性阻塞性肺病 (COPD)、哮喘、肺動脈高壓和職業性肺病。根據世界衛生組織 (WHO) 的數據,全世界有超過 3.39 億人患有哮喘。慢性阻塞性肺疾病 (COPD) 每年在全世界造成超過 300 萬人死亡。

由於準確性問題、缺乏用戶友好功能和缺乏實時反饋,移動應用程序和智能吸入器用於呼吸系統疾病管理的使用已經減少,但人工智能、機器學習等。這對公司來說是一個機會開發診斷和治療設備的解決方案。

本報告重點關注呼吸醫療保健技術的創新和專利狀況、市場驅動因素和製約因素、設備需求和與進一步創新相關的新型冠狀病毒感染 (COVID-19)。有關影響、知名公司等的信息。

目錄

第 1 章戰略要點

  • 成長困難
  • 戰略要務 8 (TM)
  • 三大戰略勢在必行對市場的影響
  • 增長機會推動的增長管道引擎 (TM)

第二章調查背景和重要發現

  • 調查範圍
  • 調查方法
  • 重大增長機會:通過智能吸入器和輕便輕便的製氧機實時反饋改善患者治療效果,以增加家庭護理

第 3 章市場概覽

  • 隨著慢性呼吸道疾病的增多,需要創新技術來提高患者的生活質量。
  • 目前,各種診斷和治療醫療設備用於改善呼吸系統疾病的管理。
  • 增長因素
  • 生長抑制

第 4 章市場細分

  • 市場細分:按產品類型
  • 各種醫療器械用於診斷呼吸系統疾病
  • 治療性醫療器械是醫生和急慢性呼吸系統疾病患者的首選

第5章診斷設備:移動醫療應用

  • 診斷移動醫療應用程序提供患者教育和行為改變動機
  • 移動醫療應用程序是傳統醫療保健的一種經濟高效的替代方案,並提供許多好處。
  • 移動醫療應用支持呼吸系統疾病的診斷並增加患者參與度
  • 臨床試驗中的許多移動醫療應用旨在監測症狀,從而實現疾病的早期診斷。
  • 領先公司的移動醫療應用支持持續的症狀跟蹤和遠程患者監測
  • 開發創新移動醫療應用程序的公司應專注於基本功能和其他補充功能。

第6章診斷設備:醫學影像軟件

  • 醫學成像軟件可提高診斷準確性並支持醫生進行患者治療設計
  • 醫學影像軟件,可實現呼吸道疾病的早期準確診斷
  • 醫學圖像處理軟件可實現更好的可視化和圖像分析
  • 開發新醫學影像軟件的公司需要與 AI/ML 集成以提高疾病診斷的準確性

第 7 章治療裝置:智能吸入器

  • 智能吸入器可提高患者參與度並提高治療效果
  • 智能吸入器的主要行業趨勢:慢性呼吸道疾病的流行和數字技術的推廣
  • 吸入型吸入器取決於它們在特定疾病中的有效性、患者偏好和醫生建議。
  • 吸入疫苗、大麻和基因療法是研究和臨床試驗中的創新用途。
  • 創新專注於開發具有數據跟蹤功能的連接吸入器設備,以實現合規性和遠程監控
  • 來自主要行業參與者的智能技術專注於患者合規性和吸入器使用跟蹤
  • 創新的智能吸入器技術需要專注於高患者參與度和連接性,以實現遠程健康監測

第8章處理設備:制氧機

  • 氧氣濃縮器是一種具有成本效益的長期解決方案,可為呼吸系統疾病患者持續供氧。
  • 氧氣濃縮器的選擇取決於患者的病情、氧氣需求和成本。
  • 新型冠狀病毒感染 (COVID-19) 的大流行正在推動對製氧機的需求
  • 從患者舒適度的角度來看,來自主要行業參與者的氧氣濃縮器重量輕且便於攜帶。
  • 創新制氧機需要專注於開發高流量和便攜功能

第 9 章主要公司

  • 斑馬醫學視覺
  • 查詢人工智能
  • ResApp 健康有限公司
  • 認知實驗室
  • 臨床電子校準

第 10 章增長機會

  • 增長機會 1:可提供反饋和支持的智能吸入器
  • 增長機會 2:創新耐用的製氧機
  • 增長機會 3:創新的移動醫療應用

第11章主要專利

  • 移動醫療應用專利
  • 醫學影像軟件專利
  • 吸入器專利
  • 制氧機專利

第12章聯繫方式

  • 主要意見領袖

下一步

目錄
Product Code: D9F9

Smart and Portable Solutions Are In Demand

Respiratory diseases are related to the airways and the structures of the lungs. They can affect air sacs, interstitium, blood vessels, pleura, and chest wall. Common respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and occupational lung disease. According to the World Health Organization, more than 339 million people have asthma globally (it is common in children). COPD is the cause of more than 3 million deaths around the world every year.

Problems with accuracy, a lack of user-friendly features, and an inability to provide real-time feedback have restrained the use of mobile applications and smart inhalers for respiratory disease management but created opportunities for companies developing artificial intelligence, machine learning, and other solutions for diagnostic and therapeutic devices.

This growth opportunity-technology report explores innovations and patents in this space and provides more details about notable companies that are making strides in research and development. It includes explanations about the drivers and restraints that will shape the market through the middle of the decade, and touches on the effects of the COVID-19 pandemic related to the demand for devices and further innovations. Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. They can offer their drugs with an innovative inhaler device.

Table of Contents

1.0 Strategic Imperatives

  • 1.1. Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • 1.2. The Strategic Imperative 8™
  • 1.3. The Impact of the Top 3 Strategic Imperatives on the Respiratory Health Management Industry
  • 1.4. Growth Opportunities Fuel the Growth Pipeline Engine™

2.0 Research Context and Key Findings

  • 2.1. Research Scope
  • 2.2. Research Methodology
  • 2.3. Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity

3.0 Market Overview

  • 3.1. The Increasing Burden of Chronic Respiratory Diseases Calls For Innovative Technology that Can Improve Patients' Quality of Life by Enabling Better Management
  • 3.2. A Broad Range of Diagnostic and Therapeutic Medical Devices Are Currently Used That Enable Better Management of Respiratory Diseases
  • 3.3. Growth Drivers
  • 3.4. Growth Restraints

4.0 Market Segmentation

  • 4.1. Market Segmentation by Product Type
  • 4.2. A Wide Range of Medical Devices Are Used for the Diagnosis of Respiratory Diseases
  • 4.3. Therapeutic Medical Devices are Preferred by Physicians and Patients for Acute and Chronic Respiratory Conditions

5.0 Diagnostic Devices: Mobile Medical Applications

  • 5.1. Mobile Medical Applications Designed for Diagnosis Offer Education and Behavioural Change Motivation to The Patients
  • 5.2. Mobile Medical Applications are a Cost-effective Alternative to Traditional Healthcare with Multiple Benefits
  • 5.3. Mobile Medical Applications Support the Diagnosis of Respiratory Diseases and Increase Patient Engagement
  • 5.4. Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis
  • 5.5. Mobile Medical Applications Offered by the Key Participants are Enabling Continuous Symptom Tracking and Remote Monitoring of the Patient
  • 5.6. Entities Developing Innovative Mobile Medical Applications Should Focus On Must-Have Features along with Other Complementary Features

6.0 Diagnostic Devices: Medical Imaging Software

  • 6.1. Medical Imaging Software Improves Diagnostic Accuracy and Supports Doctors in Designing Better Treatment for Patients
  • 6.2. Medical Imaging Software Enables Early and Accurate Respiratory Disease Diagnosis
  • 6.3. Medical Imaging Software Offered by Key Participants Provides Better Visualization and Enables Improved Image Analysis
  • 6.4. Market Participants Developing New Medical Imaging Software Should Integrate this with AI/ML to Improve its Disease Diagnosis Accuracy

7.0 Therapeutic Devices: Smart Inhalers

  • 7.1. Smart Inhalers Enable High Patient Engagement and Improve Treatment Effectiveness
  • 7.2. Growing Prevalence of Chronic Respiratory Diseases and Push for Digital Technologies are the Key Industry Trends for Smart Inhalers
  • 7.3. Choice of Inhalation Type Depends on its Effectiveness in Certain Diseases, the Patient's Preference, and the Doctor's Recommendation
  • 7.4. Inhaled Vaccines, Cannabis, and Gene Therapy are the Innovative Applications under Research and Clinical Trial
  • 7.5. Technological Innovations are Focusing on Development of Connected Inhaler Devices with Data Tracking Capability that Enable Compliance and Remote Monitoring
  • 7.6. The Smart Technologies Offered by the Key Industry Participants Focus on Tracking the Medication Adherence and Inhaler Usage of the Patient
  • 7.7. Innovative Smart Inhaler Technologies Should Focus on High Patient Engagement and Connectivity for Remote Monitoring of Health Condition

8.0 Therapeutic Devices: Oxygen Concentrators

  • 8.1. Oxygen Concentrators are a Cost-effective Long-Term Solution for Continuous Oxygen Supply to Patients with Respiratory Disease
  • 8.2. Selection of the Oxygen Concentrator Depends on the Patient's Disease Condition, Oxygen Requirements, and its Costs
  • 8.3. The COVID-19 Pandemic is Driving the Demand for Oxygen Concentrators
  • 8.4. Oxygen Concentrators Offered by the Key Industry Participants are Lightweight and Portable to Ensure Patient Comfort During Use
  • 8.5. Innovative Oxygen Concentrators Should Focus on the Development of High Flow Rate and Portability Features

9.0 Companies to Action

  • 9.1. Zebra Medical Vision
  • 9.2. Qure AI
  • 9.3. ResApp Health Limited
  • 9.4. Cognita Labs
  • 9.5. Clin-e-cal

10.0 Growth Opportunities

  • 10.1. Growth Opportunity 1: Smart Inhaler Capable of Providing Feedback and Support
  • 10.1. Growth Opportunity 1: Smart Inhaler Capable of Providing Feedback and Support (continued)
  • 10.2. Growth Opportunity 2: Innovative and Durable Oxygen Concentrators
  • 10.2. Growth Opportunity 2: Innovative and Durable Oxygen Concentrators (continued)
  • 10.3. Growth Opportunity 3: Innovative Mobile Medical Applications
  • 10.3. Growth Opportunity 3: Innovative Mobile Medical Applications (continued)

11.0 Key Patents

  • 11.1. Mobile Medical Application Patents
  • 11.2. Medical Imaging Software Patents
  • 11.3. Inhaler Patents
  • 11.4. Oxygen Concentrator Patents

12.0 Contacts

  • 12.1. Key Opinion Leaders

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • Legal Disclaimer